Cure My Disease

Don't miss your cure!

 Log in / Sign up

New polio vaccine trial aims to protect the youngest

NCT ID NCT05654467

NEW Recruiting now ⭐️ VACCINE ⭐️ Sponsor: PATH Source: ClinicalTrials.gov ↗

First seen May 16, 2026 · Last updated May 16, 2026

Summary

This study tests a new oral polio vaccine (nOPV3) in healthy young children, infants, and newborns to see if it is safe and triggers a strong immune response. About 1,500 participants in Panama will receive either the new vaccine or an existing one. The goal is to find a safer and more effective way to prevent polio.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLIOMYELITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cevaxin - 24 de Diciembre

    RECRUITING

    Panama City, Panama

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Cevaxin - Chorrera

    RECRUITING

    Panama City, Panama

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Cevaxin-- Avenida Mexico

    RECRUITING

    Panama City, Panama

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

POLIOMYELITIS